Immediate Impact
41 standout
Citing Papers
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
2024 Standout
A Review on Colistin Resistance: An Antibiotic of Last Resort
2024 Standout
Works of Radan Keil being referenced
Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis
2016
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Radan Keil | 246 | 167 | 77 | 99 | 39 | 405 | |
| John H. Colebatch | 137 | 50 | 59 | 44 | 27 | 361 | |
| Koji Nanmoku | 133 | 55 | 66 | 45 | 39 | 391 | |
| Sara A. Mansfield | 164 | 124 | 55 | 146 | 41 | 433 | |
| Kathryn Pratschke | 171 | 168 | 44 | 49 | 34 | 395 | |
| A Siegal | 125 | 117 | 28 | 99 | 39 | 365 | |
| Anna Fábián | 159 | 77 | 113 | 103 | 59 | 411 | |
| Ashok Shende | 124 | 111 | 58 | 35 | 25 | 385 | |
| João Firmino‐Machado | 155 | 69 | 51 | 53 | 42 | 365 | |
| Shigeyuki Aoki | 96 | 205 | 44 | 77 | 51 | 388 | |
| Diethelm Ag | 166 | 83 | 55 | 38 | 40 | 372 |
All Works
Loading papers...